medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2018, Number 6

<< Back Next >>

Ann Hepatol 2018; 17 (6)

Association of Parity in Patients with Chronic Liver Disease

Golabi P, Fazel S, Otgonsuren M, Escheik C, Sayiner M, Younossi ZM

Language: English
References: 41
Page: 1035-1041
PDF size: 151.27 Kb.


ABSTRACT

Introduction and aim. The impact of type of liver disease on parity rates hasn’t been described. Our aim was to assess the parity rates among women with CLD. Material and methods. The National Health and Nutrition Examination Survey-III (1988- 1994) data were used to identify adult female participants with a diagnosis of CLD. Participants were asked about their reproductive health status. Parity was defined as having at least one live birth. Hepatic ultrasound, serologic, medical examination and clinical data were available to determine the presence and type of CLD. Body mass index (kg/m2) was divided into 3 categories (‹ 30; 30- 35; 36+). Results. A total of 3,502 (865 NAFLD, 737 other CLD, 1,901 control) subjects were included. Patients with NAFLD were more likely to have at least one live birth than patients with other CLD and controls (77% in NAFLD vs. 72% in controls). Multivariate analysis revealed that presence of CLD other than NAFLD (OR: 0.46 [95% CI, 0.34-0.63]) and having a college or higher degree (OR: 0.48 [95% CI, 0.34-0.68]) were negatively associated while having low income (OR: 11.06 [95% CI, 6.86-17.82]) and being African American (OR: 3.93 [95% CI, 2.59-5.98]) were positively associated with having at least one live birth. Conclusions. This study revealed that patients with CLD other than NAFLD were less likely to have at least one live birth. NAFLD and obesity were associated with higher rates of live births which can potentially be explained by weight gain post live birth leading to obesity and its associated-NAFLD.


REFERENCES

  1. Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mishra A. Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study. BMJ Open 2014; 4: e004318.

  2. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011; 9: 524-30.e1; quiz e60.

  3. Stepanova M, Aquino R, Alsheddi A, Gupta R, Fang Y, Younossi Z. Clinical predictors of fibrosis in patients with chronic liver disease. Aliment Pharmacol Ther 2010; 31: 1085-94.

  4. Roberts HW, Utuama OA, Klevens M, Teshale E, Hughes E, Jiles R. The contribution of viral hepatitis to the burden of chronic liver disease in the United States. Am J Gastroenterol 2014; 109: 387-93; quiz 386, 394.

  5. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103: 2727-36; quiz 2737.

  6. World Gastroenterology Organization Global Guidelines- Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. http://www.worldgastroenterology.org/guidelines/ global- guidelines/nafld-nash/nafld-nash-english. Published 2012.

  7. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease- Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84.

  8. Golabi P, Sayiner M, Fazel Y, Koenig A, Henry L, Younossi ZM. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Expert Rev Gastroenterol Hepatol 2016; 10: 63-71.

  9. Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016; 65: 1017-25.

  10. Mishra A, Younossi ZM. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. J Clin Exp Hepatol 2012; 2: 135-44.

  11. Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis 2016; 20: 205-14.

  12. National Center for Health Statistics: Analytical and Reporting Guidelines: The Third National Health and Nutritional Examination Survey, Hyattsville, MD, National Center for Health Statistics.

  13. National Center for Health Statistics: Plan and Operation of The Third National Health and Nutritional Examination Survey, Hyattsville, MD, National Center for Health Statistics.

  14. Cnattingius S, Villamor E. Weight change between successive pregnancies and risks of stillbirth and infant mortality: a nationwide cohort study. Lancet 2016; 387: 558-65.

  15. Hinkle SN, Sharma AJ, Kim SY, Park S, Dalenius K, Brindley PL, Grummer-Strawn LM. Prepregnancy obesity trends among low-income women, United States, 1999-2008. Matern Child Health J 2012; 16: 1339-48.

  16. Zeal C, Remington P, Ndiaye M, Stewart K, Stattelman-Scanlan D. The epidemiology of maternal overweight in Dane County, Wisconsin. WMJ 2014; 113: 24-7.

  17. Chopra SM, Misra A, Gulati S, Gupta R. Overweight, obesity and related non-communicable diseases in Asian Indian girls and women. Eur J Clin Nutr 2013; 67: 688-696.

  18. Melzer K, Schutz Y. Pre-pregnancy and pregnancy predictors of obesity. Int J Obes 2010; 34(Suppl. 2): S44-S52.

  19. Oken E, Taveras EM, Popoola FA, Rich-Edwards JW, Gillman MW. Television, walking, and diet: associations with postpartum weight retention. Am J Prev Med 2007; 32: 305-11.

  20. Ohlin A, Rössner S. Maternal body weight development after pregnancy. Int J Obes 1990; 14: 159-73.

  21. Linné Y, Barkeling B, Rössner S. Long-term weight development after pregnancy. Obes Rev 2002; 3: 75-83.

  22. Gunderson EP. Childbearing and obesity in women: weight before, during, and after pregnancy. Obstet Gynecol Clin North Am 2009; 36: 317-32, ix.

  23. Rössner S, Ohlin A. Pregnancy as a risk factor for obesity: lessons from the Stockholm Pregnancy and Weight Development Study. Obes Res 1995; 3(Suppl. 2): 267s - 275s.

  24. Martínez ME, Pond E, Wertheim BC, Nodora JN, Jacobs ET, Bondy M, Daneri-Navarro A, et al. Association between parity and obesity in Mexican and Mexican-American women: findings from the Ella binational breast cancer study. J Immigr Minor Health 2013; 15: 234-43.

  25. Siega-Riz AM, Herring AH, Carrier K, Evenson KR, Dole N, Deierlein A. Sociodemographic, perinatal, behavioral, and psychosocial predictors of weight retention at 3 and 12 months postpartum. Obesity 2010; 18: 1996-2003.

  26. Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, Ramey S, et al. Postpartum weight retention risk factors and relationship to obesity at 1 year. Obstet Gynecol 2015; 125: 144-52.

  27. Hill B, McPhie S, Skouteris H. The Role of Parity in Gestational Weight Gain and Postpartum Weight Retention. Women’s Health Issues 2016; 26: 123-9.

  28. Davis EM, Babineau DC, Wang X, Zyzanski S, Abrams B, Bodnar LM, Horwitz RI. Short inter-pregnancy intervals, parity, excessive pregnancy weight gain and risk of maternal obesity. Matern Child Health J 2014; 18: 554-62.

  29. Saunders JB, Davis M, Williams R. Do women develop alcoholic liver disease more readily than men? Br Med J 1981; 282: 1140-3.

  30. Nanji AA, Jokelainen K, Fotouhinia M, Rahemtulla A, Thomas P, Tipoe GL, Su GL, et al. Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1348-G1356.

  31. Becker U. The influence of ethanol and liver disease on sex hormones and hepatic oestrogen receptors in women. Dan Med Bull 1993; 40: 447-59.

  32. Lee WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am 1992; 21: 889-903.

  33. Varma RR. Course and prognosis of pregnancy in women with liver disease. Semin Liver Dis 1987; 7: 59-66.

  34. Thiele DL. Autoimmune hepatitis. Clin Liver Dis 2005; 9: 635-46, vi.

  35. Aggarwal N, Chopra S, Suri V, Sikka P, Dhiman RK, Chawla Y. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet 2011; 284: 19-23.

  36. Targher G, Rossini M, Lonardo A. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? Endocrine 2016; 51: 211-21.

  37. Brzozowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol 2009; 24: 243- 47.

  38. Ecklund LC, Usadi RS. Endocrine and reproductive effects of polycystic ovarian syndrome. Obstet Gynecol Clin North Am 2015; 42: 55-65.

  39. Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community- based cohort study. J Womens Health 2015; 24: 299-307.

  40. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS).

  41. Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr 2016; 7: 121-34.




2020     |     www.medigraphic.com